Tumor-derived lysyl oxidase-like 2 (LOXL2) promotes the expression of α-smooth muscle actin (α-SMA) and activates fibroblasts through integrin-mediated FAK activation and AKT signaling [115]. This evidence concerns the gene AKT1 and neoplasm.